Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
AbbVie's Skyrizi continues booming growth trajectory
As Humira continues its sales free fall, newer Skyrizi proved a worthy successor over the first quarter with nearly matching sales.
Zoey Becker
Apr 26, 2024 12:06pm
Gilead writes $2.4B off Trodelvy as CEO underscores focus
Apr 26, 2024 11:21am
Sponsored
MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
Apr 1, 2024 8:00am
Pfizer will charge $3.5M for its first FDA-approved gene therapy
Apr 26, 2024 10:19am
Sponsored
The biopharma “brain drain”: Finding talent to fuel innovation
Jan 26, 2024 8:00am
GSK launches mRNA patent infringement case against Pfizer
Apr 26, 2024 10:04am